EETs/PPARs activation together mediates the preventive effect of naringenin in high glucose-induced cardiomyocyte hypertrophy
Background: Cardiac hypertrophy is a key pathological process in the context of diabetic cardiomyopathy. Naringenin exhibits multiple pharmacological activities, but the effect of naringenin on cardiomyocyte hypertrophy under diabetic conditions is still far from clear. Methods: Cardiomyocyte hypert...
Main Authors: | Jie Zhang, Hongmei Qiu, Jiajun Huang, Shumei Ding, Bo Huang, Ping Zhou, Qingsong Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-01-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332218360839 |
Similar Items
-
Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes
by: Dipak Kar, et al.
Published: (2018-08-01) -
The Anti-inflammatory Effect of Soluble Epoxide Hydrolase Inhibitor and 14, 15-EET in Kawasaki Disease Through PPARγ/STAT1 Signaling Pathway
by: Na Dai, et al.
Published: (2020-08-01) -
Ophiopogonin D Reduces Myocardial Ischemia-Reperfusion Injury via Upregulating CYP2J3/EETs in Rats
by: Xiaoyan Huang, et al.
Published: (2018-09-01) -
The role of redox regulation of SERCA in cardiomyocyte hypertrophy
by: Morgan, Robert Joseph
Published: (2016) -
Novel Therapeutic Effects of Pterosin B on Ang II-Induced Cardiomyocyte Hypertrophy
by: Chang Youn Lee, et al.
Published: (2020-11-01)